# Intensity Therapeutics, Inc.: Form 8-K, filed Jun 13, 2025

- Company: [Intensity Therapeutics, Inc.](/companies/ints.md) (CIK 1567264)
- Form: 8-K
- Filed: 2025-06-13
- Accepted by EDGAR: Jun 13, 2025, 16:10 ET
- Period: 2025-06-11
- Accession: 0001628280-25-031311
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/intensity-20250611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1567264/000162828025031311/intensity-20250611.htm

Filed Jun 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-031311. Last ingested by Listed: Nov 5, 2026, 12:12 ET. No prices; not investment advice.